Cancer treatments, despite their increasing effectiveness, carry a significant risk of gamete toxicity. Women of reproductive age are commonly offered fertility preservation (FP) before starting their treatment. However, few studies have analyzed the long-term reproductive outcomes of these interventions, nor how patients ultimately use or do not use the FP options once in remission. This project aims to better understand the effectiveness, utilization, and psychological impacts of these strategies. This work is part of an effort to understand and evaluate fertility preservation practices implemented for women of reproductive age undergoing cancer treatment at the Amiens-Picardie University Hospital (CHU). Its objective is to document patient pathways, clinical decisions, techniques employed, and reproductive outcomes observed after remission, in order to identify potential areas for improvement in the support and follow-up of these patients, thereby enhancing the overall quality and coordination of care. This work is conducted alongside the development of a fertility observatory at the Department of Medicine and Reproductive Biology, CHU Amiens-Picardie.
Study Type
OBSERVATIONAL
Enrollment
102
CHU Amiens Picardie
Amiens, France
RECRUITINGOccurrence of an identifiable reproductive outcome
Identifiable reproductive outcome are Spontaneous pregnancy, Use of preserved gametes or ovarian tissue (whether or not resulting in pregnancy), Use of donor oocytes, Discontinuation of the parenthood project
Time frame: 1 year
Type of fertility preservation method performed
Time frame: 1 year
Time interval (in months) between diagnosis and fertility preservation
Time frame: 1 year
Correlation between Age and occurance of an identifiable reproductive outcome
Identifiable reproductive outcome are Spontaneous pregnancy, Use of preserved gametes or ovarian tissue (whether or not resulting in pregnancy), Use of donor oocytes, Discontinuation of the parenthood project
Time frame: 1 year
Time interval (in months) between fertility preservation and initiation of potentially gonadotoxic treatment
Time frame: 1 year
Number of type of cancer associated with identifiable reproductive outcome
Identifiable reproductive outcome are Spontaneous pregnancy, Use of preserved gametes or ovarian tissue (whether or not resulting in pregnancy), Use of donor oocytes, Discontinuation of the parenthood project
Time frame: 1 year
Correlation between type of treatment and occurence of an identifiable reproductive outcome
Identifiable reproductive outcome are Spontaneous pregnancy, Use of preserved gametes or ovarian tissue (whether or not resulting in pregnancy), Use of donor oocytes, Discontinuation of the parenthood project
Time frame: 1 year
Correlation between family status and occurence of an identifiable reproductive outcome
Identifiable reproductive outcome are Spontaneous pregnancy, Use of preserved gametes or ovarian tissue (whether or not resulting in pregnancy), Use of donor oocytes, Discontinuation of the parenthood project
Time frame: 1 year
Time interval (in months) between completion of treatment and pregnancy attempt (spontaneous or medically assisted)
Time frame: 1 year
Actual utilization rate of preserved material
Time frame: 1 year
Success rate of reuse attempts
Time frame: 1 year
Proportion of patients who ultimately did not pursue parenthood
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.